Trial Profile
Phase 1/2 Study of Decitabine Alone and/or in Combination With Chemotherapy and/or Cytokine Induced Killer Cell Transfusion in Patients With Relapsed or Refractory Solid Tumors and B Cell Lymphomas
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 04 Jan 2018
Price :
$35
*
At a glance
- Drugs Decitabine (Primary) ; Antineoplastics; Cytokine-induced killer cell therapy
- Indications B-cell lymphoma; Solid tumours
- Focus Biomarker; Therapeutic Use
- 04 Mar 2013 New trial record